To access this element change to forms mode OFF
Grant Award View - GA30197
Engineering chimeric antigen receptor T cell signals to generate...
GA ID:
GA30197
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$519,339.80
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Engineering chimeric antigen receptor T cell signals to generate effective anti-tumour responses
Purpose:
Immunotherapy using genetically engineered killer cells, redirected towards a patients tumour, has revolutionised the way we treat cancer. While these treatments have been very effective, they are not without side effects. This study will enable the design of tailored and safe immunotherapy treatments so that immune responses can be tailored to the tumour type. This research will help design better therapies for cancer patients.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1162229
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA